Viatris VTRS Stock
Viatris Price Chart
Viatris VTRS Financial and Trading Overview
Viatris stock price | 8.66 USD |
Previous Close | 9.87 USD |
Open | 9.84 USD |
Bid | 9.86 USD x 4000 |
Ask | 9.87 USD x 1400 |
Day's Range | 9.82 - 9.89 USD |
52 Week Range | 8.74 - 12.4 USD |
Volume | 1.07M USD |
Avg. Volume | 8.9M USD |
Market Cap | 11.81B USD |
Beta (5Y Monthly) | 1.14 |
PE Ratio (TTM) | 6.519868 |
EPS (TTM) | -0.53 USD |
Forward Dividend & Yield | 0.48 (4.86%) |
Ex-Dividend Date | November 22, 2023 |
1y Target Est | 14.11 USD |
VTRS Valuation Measures
Enterprise Value | 29.08B USD |
Trailing P/E | 6.519868 |
Forward P/E | 3.5160716 |
PEG Ratio (5 yr expected) | -1.32 |
Price/Sales (ttm) | 0.76367885 |
Price/Book (mrq) | 0.56603235 |
Enterprise Value/Revenue | 1.88 |
Enterprise Value/EBITDA | 5.895 |
Trading Information
Viatris Stock Price History
Beta (5Y Monthly) | 1.14 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 12.4 USD |
52 Week Low | 8.74 USD |
50-Day Moving Average | 9.34 USD |
200-Day Moving Average | 9.83 USD |
VTRS Share Statistics
Avg. Volume (3 month) | 8.9M USD |
Avg. Daily Volume (10-Days) | 8.44M USD |
Shares Outstanding | 1.2B |
Float | 1.2B |
Short Ratio | 3.79 |
% Held by Insiders | 0.32% |
% Held by Institutions | 80.31% |
Shares Short | 32.33M |
Short % of Float | 3.08% |
Short % of Shares Outstanding | 2.68% |
Dividends & Splits
Trailing Annual Dividend Rate | 0.48 |
Trailing Annual Dividend Yield | 4.86% |
5 Year Average Dividend Yield | 89.00% |
Payout Ratio | 0.3179 |
Last Split Factor | 3:2 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | September 30, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 11.84% |
Operating Margin (ttm) | 14.63% |
Gross Margin | 42.92% |
EBITDA Margin | 31.89% |
Management Effectiveness
Return on Assets (ttm) | 2.74% |
Return on Equity (ttm) | 9.14% |
Income Statement
Revenue (ttm) | 15.47B USD |
Revenue Per Share (ttm) | 12.85 USD |
Quarterly Revenue Growth (yoy) | -3.30% |
Gross Profit (ttm) | 7.03B USD |
EBITDA | 4.93B USD |
Net Income Avi to Common (ttm) | 1.83B USD |
Diluted EPS (ttm) | 1.51 |
Quarterly Earnings Growth (yoy) | -6.40% |
Balance Sheet
Total Cash (mrq) | 1.39B USD |
Total Cash Per Share (mrq) | 1.16 USD |
Total Debt (mrq) | 18.62B USD |
Total Debt/Equity (mrq) | 89.26 USD |
Current Ratio (mrq) | 1.6 |
Book Value Per Share (mrq) | 17.393 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.46B USD |
Levered Free Cash Flow (ttm) | 3.97B USD |
Profile of Viatris
Country | United States |
State | PA |
City | Canonsburg |
Address | 1000 Mylan Boulevard |
ZIP | 15317 |
Phone | 724 514 1800 |
Website | https://www.viatris.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 38000 |
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
Q&A For Viatris Stock
What is a current VTRS stock price?
Viatris VTRS stock price today per share is 8.66 USD.
How to purchase Viatris stock?
You can buy VTRS shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Viatris?
The stock symbol or ticker of Viatris is VTRS.
Which industry does the Viatris company belong to?
The Viatris industry is Drug Manufacturers-Specialty & Generic.
How many shares does Viatris have in circulation?
The max supply of Viatris shares is 1.19B.
What is Viatris Price to Earnings Ratio (PE Ratio)?
Viatris PE Ratio is now.
What was Viatris earnings per share over the trailing 12 months (TTM)?
Viatris EPS is -0.53 USD over the trailing 12 months.
Which sector does the Viatris company belong to?
The Viatris sector is Healthcare.
Viatris VTRS included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 17601.05 USD — |
+0.87
|
8.38B USD — | 17181.27 USD — | 17716.52 USD — | — - | 8.38B USD — |
S&P 500 INDEX SPX | 5670.97 USD — |
+0.67
|
2.76B USD — | 5571.48 USD — | 5695.31 USD — | — - | 2.76B USD — |
S&P 500 (Yahoo.com) GSPC | 5670.97 USD — |
+0.67
|
2.74B USD — | 5571.48 USD — | 5695.31 USD — | — - | 2.74B USD — |
Nasdaq Factor Family US Value I NQFFUSV | 1805.39 USD — |
+1.11
|
— — | 1770.24 USD — | 1807.3 USD — | — - | — — |
Nasdaq Next Generation 100 Inde NGX | 1190.09 USD — |
+1.39
|
— — | 1160.42 USD — | 1194.59 USD — | — - | — — |
NASDAQ Biotechnology NBI | 4209.36 USD — |
+1.85
|
— — | 4100.47 USD — | 4211.44 USD — | — - | — — |
NASDAQ HealthCare IXHC | 942.47 USD — |
+1.43
|
— — | 920.56 USD — | 943.62 USD — | — - | — — |
Dorsey Wright Momentum Plus Div DWAMY | 1532.42 USD — |
+1.49
|
— — | 1494.75 USD — | 1533.6 USD — | — - | — — |
NASDAQ Q 50 NXTQ | 795.02 USD — |
+1.44
|
— — | 775.23 USD — | 798.39 USD — | — - | — — |
NASDAQ Global Select Market Com NQGS | 8613.57 USD — |
+0.85
|
— — | 8409.7 USD — | 8670.37 USD — | — - | — — |
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
Stlmt ID NASDAQ Biotechnology NBX | 4486.38 USD — |
-0.37
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
Nasdaq US Smart Pharmaceuticals NQSSPH | 1438.45 USD — |
+1.08
|
— — | 1414.44 USD — | 1439.08 USD — | — - | — — |
- {{ link.label }} {{link}}